MEMBER'S LOGINX
| Login Failure | ||||||||
|
||||||||
| Sign Up | Forgot Password? | ||||||||
- Home
- Todays Market
- Indian Stock Market Updates March 13, 2020
GLENMARK PHARMA Plunges by 14%; BSE HEALTHCARE Index Down 7.8%
Fri, 13 Mar 09:44 AM
GLENMARK PHARMA share price has plunged 14% and is presently trading at Rs 198.
Meanwhile, the BSE HEALTHCARE Index is at 11,870 (down 7.8%).
Among the top losers in the BSE HEALTHCARE Index today are GLENMARK PHARMA (down 13.8%) and DR. LAL PATHLABS LTD (down 10.2%).
Over the last one year, GLENMARK PHARMA has moved down from Rs 634 to Rs 198, registering a loss of Rs 436 (down 68.8%)..
The BSE HEALTHCARE has moved down from 14,333 to 11,870, loss of 2,463 points (down 17.2%) during the last 12 months.
The top gainers among the BSE HEALTHCARE Index stocks during this same period were ABBOTT INDIA (up 70.0%), J.B.CHEMICALS (up 41.1%) and DR. LAL PATHLABS LTD (up 37.1%).
What About the Benchmark Indices?
The BSE Sensex is at 31,221 (down 9.4%).
In the meantime, NSE Nifty is at 9,133 (down 10.1%).
Over the last 12 months, the BSE Sensex has moved down from 37,536 to 31,221, registering a loss of 6,315 points (down 20.91%).
GLENMARK PHARMA Financial Update...
GLENMARK PHARMA net profit stood at Rs 2 billion for the quarter ended December 2019, compared to a profit of Rs 1 billion a year ago. Net Sales rose 7.1% to Rs 27.4 billion during the period as against Rs 25.6 billion in October-December 2018.
For the year ended March 2019, GLENMARK PHARMA reported 5.7% decrease in net profit to Rs 7.6 billion compared to net profit of Rs 8.0 billion during FY18.
Revenue of the company grew 8.4% to Rs 99 billion during FY19.
The current Price to earnings ratio of GLENMARK PHARMA, based on rolling 12 month earnings, stands at 6.8x.
Indian Share Market Update: Top Gainers and Losers
What else is happening in the markets today? Dig in...
- TRACK NOW:
- Most Active Stocks Rs 0 to 10
- Most Active Stocks Rs 10 to 20
- BSE A Group Gainers Today
- NSE Above Rs 20 Gainers Today
- BSE Above Rs 20 Gainers Today
- BSE Sensex Gainers Today
- BSE Small Cap Gainers Today
- BSE 500 Gainers Today
- BSE A Group Losers Today
- Most Active Stocks Rs 1 to 2
- NSE Above Rs 20 Losers Today
- ANALYSE:
- TCS
- HDFC BANK
- ITC LIMITED
- ONGC
- HINDUSTAN UNILEVER
- SBI
Stock Market Updates
Sensex Surges 1,266 Points; Nifty Ends Above 9,100 Mark (Today's Market)
Apr 9, 2020 ClosingIndian share markets witnessed buying interest throughout the day and ended on a strong note.
VOLTAS Surges by 6%; BSE CAPITAL GOODS Index Up 1.6% (Today's Market)
Apr 9, 2020 03:33 PMVOLTAS share price has surged by 6% and its current market price is Rs 515. The BSE CAPITAL GOODS is up by 1.6%. The top gainers in the BSE CAPITAL GOODS Index are VOLTAS (up 6.0%) and HEG (up 10.0%). The top losers are THERMAX (down 0.6%) and KALPATARU POWER (down 0.6%).
MARUTI SUZUKI Surges by 13%; BSE AUTO Index Up 10.2% (Today's Market)
Apr 9, 2020 03:33 PMMARUTI SUZUKI share price has surged by 13% and its current market price is Rs 5,399. The BSE AUTO is up by 10.2%. The top gainers in the BSE AUTO Index are MARUTI SUZUKI (up 12.9%) and MRF LTD. (up 5.2%).
LUPIN Surges by 13%; BSE HEALTHCARE Index Up 3.4% (Today's Market)
Apr 9, 2020 03:33 PMLUPIN share price has surged by 13% and its current market price is Rs 798. The BSE HEALTHCARE is up by 3.4%. The top gainers in the BSE HEALTHCARE Index are LUPIN (up 12.7%) and DIVIS LABORATORIES (up 6.2%). The top losers are J.B.CHEMICALS (down 0.2%) and PROCTER & GAMBLE HEALTH (down 1.2%).
TATA ELXSI Surges by 11%; BSE IT Index Up 1.6% (Today's Market)
Apr 9, 2020 03:29 PMTATA ELXSI share price has surged by 11% and its current market price is Rs 712. The BSE IT is up by 1.6%. The top gainers in the BSE IT Index are TATA ELXSI (up 11.1%) and FIRSTSOURCE SOL. (up 12.2%). The top losers is TECH MAHINDRA (down 2.4%).
TITAN Surges by 12%; BSE 500 Index Up 3.8% (Today's Market)
Apr 9, 2020 03:29 PMTITAN share price has surged by 12% and its current market price is Rs 1,040. The BSE 500 is up by 3.8%. The top gainers in the BSE 500 Index are TITAN (up 12.5%) and MARUTI SUZUKI (up 14.1%). The top losers are BLUE DART EXPRESS and UPL .
View More Indian Share Market NewsMost Popular
Sorry Warren Buffett, I'm Following This Man Instead of You in 2020(The 5 Minute Wrapup)
Mar 30, 2020This man warned of an impending market correction while everyone else was celebrating the renewed optimism in early 2020...
One Stock that is All Charged Up for the Post Coronavirus Rebound(The 5 Minute Wrapup)
Apr 1, 2020A stock with strong moat is currently trading near 5-year lows.
A Safe Stock to Lockdown Now(The 5 Minute Wrapup)
Apr 2, 2020The market crashc has made strong, established brands attractive. Here's a stock to make the most of this opportunity...
The Insiders See a Buying Opportunity in These Smallcaps Amid Coronavirus Outbreak(Profit Hunter)
Mar 31, 2020The promoters are buying these smallcaps amid the coronavirus outbreak.
How to Identify a Market Rebound(Fast Profits Daily)
Mar 27, 2020This very useful indicator can spot a market bottom.
MoreOUR TOP 5 IDEAS
- How to Trade the Coronavirus Crash - Download this FREE Report Now
- Are You Making One of These 15 Costly Mistakes While Investing. Learn more!
- A Guide to some of the Most Lucrative Stocks in the Market. Download For Free!
- Free Report: The Secret to Increasing Your Trading Profits Daily!
- Find Out Our Top 7 Bluechips for 2020 Virtually FREE. Click Here Now!
S&P BSE SENSEX
Apr 9, 2020 (Close)
OTHER USEFUL LINKS
MARKET STATS
ABOUT EQUITYMASTER
Since 1996, Equitymaster has been the source for honest and credible opinions on investing in India. With solid research and in-depth analysis Equitymaster is dedicated towards making its readers- smarter, more confident and richer every day. Here's why hundreds of thousands of readers spread across more than 70 countries Trust Equitymaster.
FREE NEWSLETTERS
PREMIUM PRODUCTS
QUICK LINKS
APPS
Copyright © Equitymaster Agora Research Private Limited.
Whitelist | Refer | Terms | Privacy | Contact | About | Sitemap
Equitymaster Agora Research Private Limited (Research Analyst) 103, Regent Chambers, Above Status Restaurant, Nariman Point, Mumbai - 400 021. India.
Telephone: +91-22-61434055. Fax: +91-22-22028550. Email: info@equitymaster.com. Website: www.equitymaster.com. CIN:U74999MH2007PTC175407
All rights reserved. Any act of copying, reproducing or distributing this newsletter whether wholly or in part, for any purpose without the permission of Equitymaster is strictly prohibited and shall be deemed to be copyright infringement.
LEGAL DISCLAIMER: Equitymaster Agora Research Private Limited (Research Analyst) bearing Registration No. INH000000537 (hereinafter referred as 'Equitymaster') is an independent equity research Company. Equitymaster is not an Investment Adviser. Information herein should be regarded as a resource only and should be used at one's own risk. This is not an offer to sell or solicitation to buy any securities and Equitymaster will not be liable for any losses incurred or investment(s) made or decisions taken/or not taken based on the information provided herein. Information contained herein does not constitute investment advice or a personal recommendation or take into account the particular investment objectives, financial situations, or needs of individual subscribers. Before acting on any recommendation, subscribers should consider whether it is suitable for their particular circumstances and, if necessary, seek an independent professional advice. This is not directed for access or use by anyone in a country, especially, USA, Canada or the European Union countries, where such use or access is unlawful or which may subject Equitymaster or its affiliates to any registration or licensing requirement. All content and information is provided on an 'As Is' basis by Equitymaster. Information herein is believed to be reliable but Equitymaster does not warrant its completeness or accuracy and expressly disclaims all warranties and conditions of any kind, whether express or implied. Equitymaster may hold shares in the company/ies discussed herein. As a condition to accessing Equitymaster content and website, you agree to our Terms and Conditions of Use, available here. The performance data quoted represents past performance and does not guarantee future results.
SEBI (Research Analysts) Regulations 2014, Registration No. INH000000537.
Equitymaster requests your view! Post a comment on "GLENMARK PHARMA Plunges by 14%; BSE HEALTHCARE Index Down 7.8%". Click here!
Comments are moderated by Equitymaster, in accordance with the Terms of Use, and may not appear
on this article until they have been reviewed and deemed appropriate for posting.
In the meantime, you may want to share this article with your friends!